$60.780
-2.419 (-3.98%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
SPRB-Prognose durch Analyse ähnlicher Charts
Alphio's SPRB stock price prediction model matches the current Spruce Biosciences, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.25 (+0.78%). The 1-week path is $61.97 (+1.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Spruce Biosciences, Inc-Aktien kaufen?
Spruce Biosciences Inc is a good buy right now due to its recent price movement and positive clinical developments. The current price is $60.78, which is significantly below the analyst price target of $144 from Citizens, indicating a potential upside of 137%. Additionally, the stock has shown a strong 5-day change of +17.84% and a remarkable 1-year change of +520.20%, reflecting positive momentum. However, investors should be cautious of the negative earnings report with an EPS of -6.68, which missed estimates by 39.46%, indicating ongoing profitability challenges.
SPRB schloss am Friday bei $60.78, nachdem der Kurs -3.98% fallen
Spruce Biosciences, Inc (SPRB) last closed at $60.78, losing -3.98%. These facts feed the 1-day and 1-week SPRB price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Spruce Biosciences, Inc (SPRB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf SPRB am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für SPRB
Historically the probability of a positive August return for SPRB is 0.00%. December offers the highest probability of a positive month at 51.16%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.